HBF Crystal Ball To Honor Dr. Anna Lok as Distinguished Scientist 2008!
DOYLESTOWN, PA (April 9, 2008)
WHAT: Hepatitis B Foundation 2008 Crystal Ball Gala
WHEN: Saturday, April 12, 2008
Cocktails will be served at 7PM and dinner will be served at 8PM.
WHERE: The Doylestown Country Club
401 Pebble Hill Road, Doylestown, PA 18901
CRYSTAL BALL GALA PROGRAM: The Foundation will present its Distinguished Scientist Award to Anna Lok, MD. Dr. Lok’s work has been among the most important in the field, and her dedication and commitment to the health of those affected by hepatitis B care and dynamic advocacy has significantly advanced the Foundation’s mission.
Anna Lok, MD, is a professor of internal medicine and the director of clinical hepatology at the University of Michigan Medical Center. Dr. Lok graduated from the medical school at the University of Hong Kong and received her training in hepatology under the late Professor Dame Sheila Sherlock at the Royal Free Hospital in London.
Dr. Lok is a world renowned hepatologist and one of the premier leaders in hepatitis B research. She has made seminal contributions to our understanding of the natural history of hepatitis B and the role of hepatitis B virus genotypes and variants in the outcome of chronic hepatitis B infection. She has also made important contributions to the treatment of hepatitis B. She has published more than 250 papers on viral hepatitis and liver diseases. In addition to her research contributions, Dr. Lok has also played a major role in educating the medical community as well as the lay public on hepatitis B. She is a co-author of the American Association for the Study of Liver Diseases Practice Guidelines on Management of Hepatitis B, and served on the Consensus panels for the European Association for the Study of the Liver on Management of Hepatitis B and Hepatitis C. She also co-organized the 2000 and 2006 NIH Meetings on Management of Hepatitis B. Dr. Lok served as co-chair of the American Liver Foundation THINK B Campaign.
In addition to hepatitis B, Dr. Lok is also actively involved in research projects on hepatitis C, liver cancer and liver transplantation. Her research is funded by the NIH, CDC, and various foundations.
Dr. Lok has mentored more than thirty fellows and junior faculty, many of whom have stayed in academic medicine and have become independently successful investigators.
During her distinguished career, she has received numerous awards for research and teaching. In 1996, Dr. Lok received the Hugh R. Butt Award for Distinguished Achievement in Clinical Research in Hepatology from the American Digestive Health Foundation. In 2002 she was awarded the University of Texas Southwestern Medical Foundation’s Distinguished Visiting Professorship that honors women in science and medicine. In 2005, she received a Freedom to Discover Award from the Bristol-Myers Squibb Foundation for her contributions to infectious diseases research. Dr. Lok is the recipient of the Hepatitis B Foundation, 2008 Distinguished Scientist Award, and will be recognized as one of the American Gastroenterological Association Foundation 2008 Outstanding AGA Women in Science
Dr. Lok served on the governing board of the American Association for the Study of Liver Diseases from 2001-2003, and as an Associate Editor for HEPATOLOGY from 2001-2006. She is currently Co-Editor of the Journal of Viral Hepatitis, and a delegate of the hepatitis panel of the US-Japan Medical Science Cooperative Program.
About the Hepatitis B Foundation
The Hepatitis B Foundation is the only national nonprofit organization solely dedicated to finding a cure and improving the quality of life for those affected with hepatitis B worldwide through research, education and patient advocacy. The Foundation is located in the new Pennsylvania Biotechnology Center, which it created to expand and accelerate its research mission. For more information, visit www.hepb.org or call (215) 489-4900.